Latin America Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2016 - 2021)

  • ID: 3784735
  • Report
  • Region: Latin America
  • 98 pages
  • Mordor Intelligence
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen
  • Bayer
  • Cerulean Pharma
  • Genentech
  • GlaxoSmithKline
  • MORE
The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life routines lead to the growing incidence of the disease. Renal cell carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma, is the most common type of kidney cancer. About 9 out of 10 kidney cancers are renal cell carcinomas.

The Kidney Cancer Market is expected to grow modestly from USD 113 million in 2015 to USD 119 million in 2020.

The Latin America kidney cancer therapeutics & diagnostic market is segmented based on:

- Type
- Renal cell carcinoma
- Transitional Cell Cancer
- Renal sarcoma
- Other rare types
- Major tests
- Cystoscopy
- Biopsy
- Intravenous pyelogram
- CT Scan an
- Kidney Ultrasound.
- Geography
- Argentina
- Brazil

In addition, the revenue generated by major drugs like Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Votrient and Sutent in the market is also discussed.

Some of the key participants in the industry include Pfizer, GlaxoSmithKline, Sanofi S.A, Roche, Novartis, Bayer, Abbott Laboratories, Genentech etc.

Drivers:

- Increasing kidney cancer cases
- Technological developments
- Drug innovations with regard to the kidney cancer
- Government initiatives
- Rise in aging populace
- Advanced health care
- Upsurge in awareness about kidney diseases and their existing therapies in the market
- Increasing health care expenditure

Restraints:

- Rise in number of patent expirations
- Rise in use of generic drugs
- Low success rate in clinical trials
- Regulatory affairs

Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen
  • Bayer
  • Cerulean Pharma
  • Genentech
  • GlaxoSmithKline
  • MORE
1. Introduction
1.1 Market Definition
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Drivers
3.1.1 Increase in the target population
3.1.2 Increase in thehealth care expenditure
3.1.3 Increased R&D Expenditure of Pharmaceutical companies
3.2 Market Restraints
3.2.1 Preference for generic drugs
3.2.2 High cost associated with the treatment
3.2.3 Low success rate in clinical trails for cancer drugs
3.2.4 Regulatory affairs – for drug development and approval
3.3 Market Opportunitites
3.4 Market Threats
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Latin America Kidney Cancer Therapeutics & Diagnostic Market, by Cancer Type
5.1.1 Renal cell carcinoma
5.1.1.1 Clear cell renal cell carcinoma
5.1.1.2 Papillary renal cell carcinoma
5.1.1.3 Chromophobe renal cell carcinoma
5.1.1.4 Other Rare types
5.1.2 Transitional cell carcinoma
5.1.3 Renal sarcoma
5.2 Latin America Kidney Cancer Therapeutics Market
5.2.1 Afinitor
5.2.3 Avastin
5.2.3 Inlyta
5.2.4 Nexavar
5.2.5 Proleukin
5.2.6 Votrient
5.2.7 Sutent
5.3 Latin America Kidney Cancer Diagnostics Market
5.3.1 Biopsy
5.3.2 Intravenous pyelogram
5.3.3 CT Scan
5.3.4 Cystoscopy
5.3.5 Nephro-ureteroscopy
5.3.6 Ultrasound
5.4 Latin America Kidney Cancer Therapeutics & Diagnostics Market, By Region
5.4.1 Argentina
5.4.2 Brazil
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Bayer
7.2 F. Hoffmann-La Roche
7.3 GlaxoSmithKline
7.4 Novartis
7.5 Pfizer
7.6 Abbott Laboratories
7.7 Amgen
7.8 Genentech
7.9 Cerulean Pharma
7.10 Seattle Genetics
8. Appendix
8.1. Abbreviations
8.2. Sources
8.3. Bibliography
8.4. Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Bayer
Hoffmann La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Amgen
Genentech
Cerulean Pharma
Seattle Genetics
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll